Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.40 |
| ▸ | APP | P05067 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.35 |
| ▸ | PDE4A | P27815 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | POLB | P06746 | 2/20 | 0.30 |
| ▸ | RAB9A | P51151 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28685473 | 1.00 | ALOX15 (0.50) | ALOX15SMN1; SMN2MEN1CYP1A2KMT2A | |
| Taurine SCHEMBL25373994 | 0.92 | LMNA (0.56) | ALOX15SMN1; SMN2MEN1CYP1A2KMT2A | |
| SCHEMBL4100132 | 0.86 | ALOX15 (0.56) | ALOX15SMN1; SMN2MEN1CYP1A2KMT2A | |
| SCHEMBL1561614 | 0.86 | ALOX15 (0.56) | ALOX15SMN1; SMN2MEN1CYP1A2KMT2A | |
| SCHEMBL4094270 | 0.85 | ALOX15 (0.55) | ALOX15SMN1; SMN2MEN1CYP1A2KMT2A | |
| SCHEMBL11773616 | 0.85 | ALOX15 (0.55) | ALOX15SMN1; SMN2MEN1CYP1A2KMT2A | |
| SCHEMBL11773387 | 0.85 | ALOX15 (0.55) | ALOX15SMN1; SMN2MEN1CYP1A2KMT2A | |
| SCHEMBL4105263 | 0.85 | ALOX15 (0.55) | ALOX15SMN1; SMN2MEN1CYP1A2KMT2A | |
| SCHEMBL11770651 | 0.85 | ALOX15 (0.55) | ALOX15SMN1; SMN2MEN1CYP1A2KMT2A | |
| SCHEMBL17234459 | 0.83 | ALOX15 (0.37) | ALOX15BLMLMNACYP2C19SLC6A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1092 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12292445-B2 | Methods of selecting subjects for treatment with metabolomic modulators | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-05-06 | — | — | US | claimed |
| WO-2024254556-A9 | BACTERIAL COMPOSITIONS FOR METABOLIZING UREMIC TOXINS | ATOSSA THERAPEUTICS, INC. (US) | 2025-01-30 | — | — | WO | claimed |
| CN-119384205-A | Preparation methods of amidino taurine applied to perovskite active layer and perovskite solar cell module | 浙江机电职业技术大学 | 2025-01-28 | — | — | CN | claimed |
| CN-119192036-A | Synthesis method of amidino taurine | 苏州华道生物药业股份有限公司 | 2024-12-27 | — | — | CN | claimed |
| WO-2024254556-A1 | BACTERIAL COMPOSITIONS FOR METABOLIZING UREMIC TOXINS | ATOSSA THERAPEUTICS, INC. (US) | 2024-12-12 | — | — | WO | claimed |
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| CN-114350331-B | Strong-adsorption salt-resistant plugging agent based on nano-silica and water-based drilling fluid | 西南石油大学 | 2023-01-31 | — | — | CN | claimed |
| CN-114113573-B | Biomarker for early prediction of cardiovascular disease (CVD) of diabetic patient and application thereof | 中国医学科学院阜外医院 | 2022-11-11 | — | — | CN | claimed |
| CN-114350331-A | Strong-adsorption salt-resistant plugging agent based on nano-silica and water-based drilling fluid | 西南石油大学 | 2022-04-15 | — | — | CN | claimed |
| CN-114113573-A | Biomarker for early prediction of cardiovascular disease (CVD) of diabetic patient and application thereof | 中国医学科学院阜外医院 | 2022-03-01 | — | — | CN | claimed |
| US-20130011364-A1 | MOLECULARLY IMPRINTED POLYMERS FOR ELIMINATING METABOLITES | FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH (DE) | 2013-01-10 | — | — | US | claimed |
| CN-102649772-A | Artificially-synthesized taurocyamine and synthetic method thereof | NINGXIA XINGPING FINE CHEMICAL STOCK CO LTD | 2012-08-29 | — | — | CN | claimed |
| EP-2091513-B1 | EJECTION LIQUID AND EJECTION METHOD | CANON KK (JP) | 2011-04-06 | — | — | EP | claimed |
| US-20100116691-A1 | BIOSENSOR FOR CONTINUOUS MONITORING OF METABOLITES AND PROTEINS AND METHODS OF MANUFACTURE THEREOF | UNIVERSITY OF CONNECTICUT (US) | 2010-05-13 | — | — | US | claimed |
| US-20100069290-A1 | EJECTION LIQUID AND EJECTION METHOD | CANON KABUSHIKI KAISHA (JP) | 2010-03-18 | — | — | US | claimed |
| EP-2091513-A2 | EJECTION LIQUID AND EJECTION METHOD | Canon Kabushiki Kaisha (JP) | 2009-08-26 | — | — | EP | claimed |
| WO-2008069012-A2 | EJECTION LIQUID AND EJECTION METHOD | CANON KABUSHIKI KAISHA (JP) | 2008-06-12 | — | — | WO | claimed |
| CN-1271403-C | Polysaccharide quantitative detecting method and system | SHANGHAI UNIVERSITY OF TRADITI (CN) | 2006-08-23 | — | — | CN | claimed |
| CN-1588007-A | Polysaccharide quantitative detecting method and system | SHANGHAI UNIV OF CHINESE MEDIC (CN) | 2005-03-02 | — | — | CN | claimed |
| US-5723496-A | ALZHEIMER'S DISEASE, ADMINISTERING AN ALKALINE SHIFTER COMPOUND OR A BUFFER, BASIFICATION | THE REGENTS OF UNIVERSITY OF CALIFORNIA (US) | 1998-03-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100069290-A1 | EJECTION LIQUID AND EJECTION METHOD | GUCY1A1, NPPA, GUCY1A2 | ALOX15 3365/4885SMN1; SMN2 880/4885MEN1 2343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.